Alector, Inc. (ALEC)
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Founded
2013
Number of Employees
244
Website
http://www.alector.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)